Delivery Order SPE2DB22D3301-SPE2DB24FY2VG
Award Date 3/18/24
Potential Completion Date 4/8/24
Potential Value $3.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price of $8,550.00 and a period of performance through March 29, 2024. It involves the supply of XEOMIN 50 unit vials, a pharmaceutical product, to DLA Troop Support Medical facilities supporting the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,931.80 firm fixed price delivery order is for the supply of 100 unit vials of the pharmaceutical product XEOMIN. The contract has a performance period ending on July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,145.50 to the Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 4564421570 units of XEOMIN 200 UNIT VIALS. The contract has a firm fixed price and an ultimate completion date of May 17, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,155.52, is for the delivery of XEOMIN 200 UNIT VIALS, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a...
- This federal contract award is a delivery order valued at $1,519.70 between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 50U PWVL 1S, a medical supply, with a completion date of June 24, 2025. The contract is a firm fixed price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $44,036.16 Firm Fixed Price Delivery Order contract is for the provision of 4,564,421,571 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract does not have a set-aside designation and has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,352.44 firm fixed-price delivery order is for the supply of XEOMIN 100 unit vials. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $3,669.68 for the supply of 4,563,451,766 units of XEOMIN 100 unit vials. The delivery order is set to be completed by February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense through an Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $10,485.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,496,211 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,934.16, is a delivery order for 4,567,933,846 units of the medication XEOMIN 200. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...